Latest Conference Articles

Hospitals often discuss the importance of reporting errors, but is lack of feedback to blame why some pharmacists may not report errors?

Automation and technology have facilitated bar code dispensing.

Matthew Grissinger, BSPharm, offers advice for health-system pharmacists on catching potential harmful medication errors.

TPN compounding machines can help reduce potential disensing errors.

In this clip, Tim Stratton, PhD, Professor of Pharmacy Practice at the University of Minnesota, discusses the role of naloxone availability in the opioid epidemic.

What are the latest drugs available in primary care and what role do they play in pharmacy practice?

Ethical dilemmas do surface from time to time in the pharmacy.

At the ASHP 2017 Summer Meeting and Exhibition held in Minneapolis, Minnesota, several speakers spoke about the misuse and abuse of opioids. In this clip, Tim Stratton, PhD, BCPS, FAPhA, Professor of Pharmacy Practice at the University of Minnesota, discusses the ethical dimensions of the opioid crisis from a pharmacy practice and public health perspective.

Pediatric patients can benefit from improved discharge medication services when transitioning from hospital to home, according to data reported in a poster presentation at the American Pharmacists Association (APhA) 2017 Annual Meeting & Exposition.

Community pharmacists can play a valuable role in preventing hospital readmissions through patient education and resolution of identified drug therapy problems, according to data reported in a poster presentation at the American Pharmacists Association (APhA) 2017 Annual Meeting & Exposition in San Francisco.

Consumers feeling overloaded by DTC pharmaceutical ads.

Thanks for following us on Twitter, Instagram, and Facebook!

In this clip taken at APhA 2017, Evan Sisson, PharmD, of VCU School of Pharmacy discusses the role of the pharmacist in counseling patients about cardiovascular medication and nutraceutical use.

Adults who receive vaccination reimbursement through an employer-sponsored pharmacy insurance benefit may be more likely to receive vaccinations, according to data revealed in a poster presentation at the American Pharmacists Association (APhA) 2017 Annual Meeting & Exposition in San Francisco.

Advocacy, patient feedback encouraged during APhA keynote address.

Public perceptions on naloxone may differ by community.

At the American Pharmacists Association 2017 meeting, an inspiring and practical session titled “Leading by Example” showed how pharmacists can leverage their value to establish health care team partnerships (eg, with health systems and physician practices) and implement programs to win pharmacy “champions,” improve patient outcomes, and reduce health care costs.

Pharmacists play an important role in helping to deal with clinical inertia.

There are several new options coming down the pipeline for patients with type 2 diabetes.

Continuing education remains an important part of a pharmacist's life, particularly those dealing with an ever-increasing population of patients with diabetes.

There are several new treatments in the pipeline that hold promise for patients with type 2 diabetes.

Sessions focuses on new diabetes treatment options.

Two new fixed-dose basal/GLP-1 receptor-agonist agents, Soliqua 100/33 (Sanofi) and Xultophy 100/3.6 (Novo Nordisk), were approved by the FDA in November 2016.

In this clip, Jeffrey Fudin, PharmD, who spoke at APHA 2017 on opioid tapering, discusses options pharmacists should consider when tapering patients.

In this clip, Jeffrey Fudin, PharmD, discusses available options in abuse-deterrent formulations of opioids.

APhA is about to kick off and we'll be there all weekend covering it live!